Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

185 trials

NCT05768178
Recruiting
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
Phase 2/3 · United Kingdom · 16 sites
Registry update: 24 Nov 2025
NCT05599139
Recruiting
Iodine Uptake After a Low Iodine Diet
Not applicable · Netherlands · 1 site
Registry update: 6 Feb 2026
NCT05503797
Recruiting
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Phase 2 · Australia, Canada, Germany, Spain, France, United Kingdom, Italy, South Korea, Netherlands, Norway, Sweden, United States · 70 sites
Registry update: 27 Jul 2026
NCT05733013
Recruiting
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
Not applicable · United States · 1 site
Registry update: 27 Apr 2026
NCT06079333
Recruiting
NEO- and Adjuvant Targeted Therapy in Braf-mutated Anaplastic Cancer of the Thyroid (NEO-ATACT Study)
Phase 2 · Netherlands · 1 site
Registry update: 12 Oct 2023
NCT06863805
Recruiting
Evaluation of the Clinical Utility of Circulating Biomarkers in Advanced Thyroid Carcinomas
Not applicable · Italy · 1 site
Registry update: 7 Mar 2025
NCT05468554
Recruiting
Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer
Phase 3 · Poland · 2 sites
Registry update: 21 Oct 2026
NCT06333587
Recruiting
Minimally Invasive Treatments of the Thyroid
Not applicable · Italy · 1 site
Registry update: 27 Mar 2024
NCT04916990
Recruiting
Improving Care for Rural Patients With Solid Tumors
Not applicable · United States · 14 sites
Registry update: 5 Feb 2026
NCT06398795
Recruiting
Dual-port Trans-subclavian Thyroid Endoscopic Surgery
Not applicable · China · 1 site
Registry update: 31 Dec 2024
NCT06523582
Recruiting
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Not applicable · Mexico · 3 sites
Registry update: 26 Jul 2024
NCT06610604
Recruiting
Health-Related Quality of Life and Emotions in Patients with Thyroid Nodules
Not applicable · China · 1 site
Registry update: 24 Sept 2024
NCT06087068
Recruiting
Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
Phase 2 · China · 1 site
Registry update: 17 Oct 2023
NCT05752604
Recruiting
Impact of Conventional Treatments and Clinical Variables on Thyroid Cancer
Not applicable · Italy · 1 site
Registry update: 3 Aug 2025
NCT06082180
Recruiting
A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer
Phase 3 · China · 1 site
Registry update: 13 Oct 2023
NCT05366881
Recruiting
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Not applicable · United States · 17 sites
Registry update: 4 Nov 2026
NCT05604963
Recruiting
Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
Not applicable · United Kingdom · 33 sites
Registry update: 5 Mar 2026
NCT05264857
Recruiting
Decision Aid and Thyroid Nodules Management
Not applicable · United States · 1 site
Registry update: 14 Oct 2025
NCT05172921
Recruiting
Environmental Factors and Thyroid Cancer
Not applicable · United States · 1 site
Registry update: 17 Jun 2026
NCT06443866
Recruiting
I-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid Cancer
Not applicable · United States · 1 site
Registry update: 5 Jun 2024

Ordered by registry start date. Freshness and sponsorship never change the order.